G, K., S, K., P, F., KK, K., S, S., GB, R., & DA, S. (2026). Core-shell nanotherapeutics for diabetic cataract and retinopathy: Current state-of-the-art and translational challenges. Drug delivery and translational research, 16(4), 1188. https://doi.org/10.1007/s13346-025-01971-0
Chicago Style (17th ed.) CitationG, Kumari, Kundu S, Famta P, Kalahasti KK, Srivastava S, Reddy GB, and Srinivasarao DA. "Core-shell Nanotherapeutics for Diabetic Cataract and Retinopathy: Current State-of-the-art and Translational Challenges." Drug Delivery and Translational Research 16, no. 4 (2026): 1188. https://doi.org/10.1007/s13346-025-01971-0.
MLA (9th ed.) CitationG, Kumari, et al. "Core-shell Nanotherapeutics for Diabetic Cataract and Retinopathy: Current State-of-the-art and Translational Challenges." Drug Delivery and Translational Research, vol. 16, no. 4, 2026, p. 1188, https://doi.org/10.1007/s13346-025-01971-0.